Publications
- Distinct Responsiveness of Tumor-Associated Macrophages to Immunotherapy of Tumors with Different Mechanisms of Major Histocompatibility Complex Class I Downregulation2021 | Faculty of Science
- Abrogation of IFN-gamma Signaling May not Worsen Sensitivity to PD-1/PD-L1 Blockade2020 | Faculty of Science
- Abrogation of IFN-γ Signaling May not Worsen Sensitivity to PD-1/PD-L1 Blockade2020 | Faculty of Science
- Establishment and characterization of a mouse tumor cell line with irreversible downregulation of MHC class I molecules2019 | Faculty of Science
- Experimental Combined Immunotherapy of Tumours with Major Histocompatibility Complex Class I Downregulation2018 | Faculty of Science
- PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression2017 | Faculty of Science
- Aspartate β-hydroxylase Regulates Expression of Ly6 Genes2024 | Faculty of Science
- Bioinformatics analysis of immune characteristics in tumors with alternative carcinogenesis pathways induced by human papillomaviruses2023 | Faculty of Science
- ARG1 mRNA Level Is a Promising Prognostic Marker in Head and Neck Squamous Cell Carcinomas2021 | Faculty of Science, Second Faculty of Medicine, First Faculty of Medicine
- CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade2021 | Faculty of Science
Loading network view...